Fake COVID-19 treatments and vaccines are abound – but the FDA is on the case.

How can the FDA tackle the inspection backlog?

We sit down with Jason Lacombe, CEO of Veratrak, to find out more about blockchain for pharma.

We catch up with Samsung Biologics about easing tech transfers and preparing plants for the future.

And the winner of The Medicine Maker 2020 Innovation Awards is…

Sputnik V (finally and definitely) starts rolling review with the EMA.

What happens when the same batch of powder gives different results when tested with different laser diffraction testing machines?

A diabetes drug repurposed for treating obesity shows promise.

Experts from our previous Power Lists discuss the challenges of leadership during these trying times.

We have vaccines. Now, pharma’s mission is to address novel variants. And vaccine hesitancy.